Global leaders unite to tackle drug-resistant bacteria

World leaders meeting in New York have backed a new set of goals and pledged to find US$100 million in funding to address the problem of drug-resistant bacteria, a global crisis that is all the more acute in the poorest countries.

Rallybio and J&J collaborate to tackle maternal-foetal blood disorder – Pharmaceutical Technology

Share this article With no approved therapies, there is a high unmet need for preventative and prenatal treatments for FNAIT. Credits: fizkes/Shutterstock.com Rallybio has announced

April 13, 2024

Decentralized trials company Science 37 to go private in deal with diagnostics startup eMed

Science 37, one of the startups that fueled the rise in decentralized clinical trials, will go private and see its one-time $1 billion valuation evaporate

January 30, 2024

New combinations and targeted therapies for acute myeloid leukemia on the horizon

The treatment landscape for acute myeloid leukemia (AML) is evolving rapidly, as research discoveries at Sylvester Comprehensive Cancer Center at the University of Miami Miller

December 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.